Expert Opin Investig Drugs
-
Publication Venue For
- Investigational drugs in phase II clinical trials for acute coronary syndromes.. 29:33-47. 2020
- Investigational dopamine antagonists for the treatment of schizophrenia.. 26:687-698. 2017
- WT1 vaccination in acute myeloid leukemia: new methods of implementing adoptive immunotherapy.. 23:417-426. 2014
- Rho-kinase inhibitors offer a new approach in the treatment of glaucoma.. 23:81-95. 2014
- Atypical antipsychotics as a possible treatment option for irritable bowel syndrome.. 22:565-572. 2013
- Tetomilast: new promise for phosphodiesterase-4 inhibitors?. 21:1845-1849. 2012
- Lonafarnib for cancer and progeria.. 21:1043-1055. 2012
- Tedizolid (TR-701): a new oxazolidinone with enhanced potency.. 21:515-522. 2012
- Vorapaxar: a novel protease-activated receptor-1 inhibitor.. 20:1445-1453. 2011
- Investigational therapies for non-muscle invasive bladder cancer.. 19:371-383. 2010
- Glioblastoma multiforme: a review of where we have been and where we are going.. 18:1061-1083. 2009
- Rivaroxaban, an oral direct factor Xa inhibitor.. 17:925-937. 2008
- Agents under investigation for the treatment and prevention of neutropenia.. 16:1831-1840. 2007
- AZD6140.. 16:225-229. 2007
- Prasugrel.. 15:1627-1633. 2006
- Targeted therapy in renal cell carcinoma.. 14:1251-1258. 2005
- The discovery of a class of novel HIV-1 maturation inhibitors and their potential in the therapy of HIV.. 14:681-693. 2005
- Novel modes of antifungal drug administration.. 13:903-932. 2004
- Eptifibatide: a potent inhibitor of the platelet receptor integrin, glycoprotein IIb/IIIa.. 8:1893-1905. 1999
- Dendritic cell-based approaches to cancer immunotherapy.. 7:1617-1627. 1998
- The therapeutic potential of a kallikrein inhibitor for treating hereditary angioedema.. 15:1077-1090. 2006